Mechano-responsive protein candidate(s)

About Vibe Pharmaceuticals

Vibe Pharmaceuticals is a private, pre-clinical biotech company leveraging a novel drug discovery platform to identify proteins that mimic the bone- and muscle-building effects of mechanical vibration. Spun out of UPenn and founded in 2019, the company is targeting significant unmet needs in age-related musculoskeletal disorders like osteoporosis and sarcopenia. Its leadership combines deep expertise in drug discovery, geriatric medicine, and skeletal biology, though the company appears to be in a very early, resource-constrained stage with a simple website suggesting limited recent public activity.

Therapeutic Areas